Publications
Dannhauser, T. M., Cleverley, M., Whitfield, T. J., Fletcher, B. C., Stevens, T., &
Walker, Z. (2014). A complex multimodal activity intervention to reduce the
risk of dementia in mild cognitive impairment-ThinkingFit: pilot and feasibility
study for a randomized controlled trial. BMC Psychiatry, 14 (1), 129-?.
doi:10.1186/1471-244X-14-129
Azam, B., Whitfield, T. J., Radford, D., Dontham, S. G., Stevens, T.,
Dannhauser, T., & Walker, Z. (2014). Trends in referred patient profiles in a
memory clinic over 20 years. Dementia (London).
doi:10.1177/1471301214539691
Amo-Korankye, S., Grant, D. (2014). Driving and mental illness audit. The
Online Journal of Clinical Audits, 6(2).
Troop, N. A., Andrews, L., Hiskey, S. & Treasure, J. (2014) Social rank and
symptom change in eating disorders: A 6-month longitudinal study. Clinical
Psychology & Psychotherapy, 21, 115-122.
Lee-Messner, H., & Stevenson, E. (2014). Hello/goodbye new families: group
work with five looked-after siblings in foster care together awaiting a move to
separate adoptive families. Journal of Child Psychotherapy, 40(3).
Fonseca, J. A. S., Ducksbury, R., Rodda, J., Whitfield, T., Nagaraj, C., Suresh,
K., ... & Walker, Z. (2015). Factors that predict cognitive decline in patients
with subjective cognitive impairment. International Psychogeriatrics, 1-7.
Curtis C, Gamez JE, Singh U, Sadowsky CH, Villena T, Sabbagh MN, Beach TG,
Duara R, Fleisher AS, Frey KA, Walker Z, Hunjan A, Holmes C, Escovar YM, Vera
CX, Agronin ME, Ross J, Bozoki A, Akinola M, Shi J, Vandenberghe R,
Ikonomovic MD, Sherwin PF, Grachev ID, Farrar G, Smith AP, Buckley CJ,
McLain R, Salloway S. (2015) Phase 3 trial of flutemetamol labeled with
radioactive fluorine 18 imaging and neuritic plaque density. JAMA Neurol.
72(3):287-94.
Ballard C, Thomas A, Gerry S, Yu L, Aarsland D, Merritt C, Corbett A, Davison C,
Sharma N, Khan Z, Creese B, Loughlin P, Bannister C, Burns A, Win SN, Walker
Z; MAIN-AD investigators. A Double-Blind Randomized Placebo-Controlled
Withdrawal Trial Comparing Memantine and Antipsychotics for the Long-Term
Treatment of Function and Neuropsychiatric Symptoms in People With
Alzheimer's Disease (MAIN-AD). J Am Med Dir Assoc. 2014 Dec 15. pii: S15258610(14)00749-X. doi: 10.1016/j.jamda.2014.11.002. [Epub ahead of print]
Walker Z, Moreno E, Thomas A, Inglis F, Tabet N, Rainer M, Pizzolato G,
Padovani A; DaTSCAN DLB Phase 4 Study Group. Clinical usefulness of
dopamine transporter SPECT imaging with 123I-FP-CIT in patients with possible
dementia with Lewy bodies: randomised study. Br J Psychiatry. 2015
Feb;206(2):145-52.
Sheehan R, Sinai A, Bass N, Blatchford P, Bohnen I, Bonell S, Courtenay K,
Hassiotis A, Markar T, McCarthy J, Mukherji K, Naeem A, Paschos D, PerezAchiaga N, Sharma V, Thomas D, Walker Z, Strydom A. Dementia diagnostic
criteria in Down syndrome. Int J Geriatr Psychiatry. 2014 Nov 3. doi:
10.1002/gps.4228. [Epub ahead of print]
Livingston G, Barber J, Rapaport P, Knapp M, Griffin M, Romeo R, King D,
Livingston D, Lewis-Holmes E, Mummery C, Walker Z, Hoe J, Cooper C. START
(STrAtegies for RelaTives) study: a pragmatic randomised controlled trial to
determine the clinical effectiveness and cost-effectiveness of a manual-based
coping strategy programme in promoting the mental health of carers of people
with dementia. Health Technol Assess. 2014 Oct;18(61):1-242.
O'Brien JT, Oertel WH, McKeith IG, Grosset DG, Walker Z, Tatsch K, Tolosa E,
Sherwin PF, Grachev ID. Is ioflupane I123 injection diagnostically effective in
patients with movement disorders and dementia? Pooled analysis of four
clinical trials. BMJ Open. 2014 Jul 3;4(7):e005122. doi: 10.1136/bmjopen-2014005122.
Grosset DG, Tatsch K, Oertel WH, Tolosa E, Bajaj N, Kupsch A, O'Brien JT, Seibyl
J, Walker Z, Sherwin P, Chen C, Grachev ID. Safety Analysis of 10 Clinical Trials
and for 13 Years After First Approval of Ioflupane 123I Injection (DaTscan). J
Nucl Med. 2014 Jun 19;55(8):1281-1287. [Epub ahead of print]
Seibyl JP, Kupsch A, Booij J, Grosset DG, Costa DC, Hauser RA, Darcourt J, Bajaj
N, Walker Z, Marek K, McKeith I, O'Brien JT, Tatsch K, Tolosa E, Dierckx RA,
Grachev ID. Individual-Reader Diagnostic Performance and Between-Reader
Agreement in Assessment of Subjects with Parkinsonian Syndrome or
Dementia Using 123I-Ioflupane Injection (DaTscan) Imaging. J Nucl Med. 2014
Jun12;55(8):1288-1296.
Zis P, McHugh P, McQuillin A, Praticò D, Dickinson M, Shende S, Walker Z,
Strydom A. Memory decline in Down syndrome and its relationship to
iPF2alpha, a urinary marker of oxidative stress. PLoS One. 2014 Jun
5;9(6):e97709.
Dean K, Jenkinson C, Wilcock G, Walker Z. The development and validation of a
patient-reported quality of life measure for people with mild cognitive
impairment. Int Psychogeriatr. 2014 Mar;26(3):487-97.
Dean K, Jenkinson C, Wilcock G, Walker Z. Exploring the experiences of people
with mild cognitive impairment and their caregivers with particular reference
to healthcare - a qualitative study. Int Psychogeriatr. 2014 Mar;26(3):475-85.
Ascoli, M., Palinski, A., Abdul-Hamid, W., & Dein, S. (2014). Cultural
consultation for Jinn and Spirit Possession in Muslim psychiatric patients: A
case series. World Cultural Psychiatry Research Review, 9(2), 65-69.
Dein S (2014) Religion and mental health: A critical appraisal of the literature.
World Association Cultural Psychiatry Research Review WCPRR June 2014: 4246.
Hiskey, S., Ayres, R., Andrews, L., & Troop, N. (2015). Support for the location
of negative posttraumatic cognitions in the diagnosis of posttraumatic stress
disorder. Personality and Individual Differences, 74, 192-195.
Dannhauser, T., Qassem, T., Bhan-Kotwal, S., Saddik, K., Lee, L., & Walker, Z.
(2014). A neuropsychological study of near infrared spectroscopy
hemoencephalography neurofeedback treatment in amnestic mild cognitive
impairment.
Qassem, T., Bebbington, P., Spiers, N., McManus, S., Jenkins, R., & Dein, S.
(2014). Prevalence of psychosis in black ethnic minorities in Britain: analysis
based on three national surveys. Social psychiatry and psychiatric
epidemiology, 1-8.